Viral load and heterosexual transmission of human immunodeficiency virus type 1

New England Journal of Medicine

Volumn 342, Issue 13, 2000, Pages 921-929

  Quinn, Thomas C ^a,b   Wawer, Maria J ^c   Sewankambo, Nelson ^d   Serwadda, David ^d   Li, Chuanjun ^b   Wabwire Mangen, Fred ^d   Meehan, Mary O ^c   Lutalo, Thomas ^d   Gray, Ronald H ^b  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c Columbia University ^*  (United States)

^d MAKERERE UNIVERSITY   (Uganda)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS RNA;

ADOLESCENT; ADULT; ARTICLE; FEMALE; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEXUAL TRANSMISSION; SEXUALLY TRANSMITTED DISEASE; VIRUS INFECTION; VIRUS LOAD; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; CIRCUMCISION, MALE; DISEASE TRANSMISSION, HORIZONTAL; EDUCATIONAL STATUS; FEMALE; HETEROSEXUALITY; HIV INFECTIONS; HIV SEROPOSITIVITY; HIV-1; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; RNA, VIRAL; TRAVEL; VIRAL LOAD;

EID: 0034732201     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM200003303421303     Document Type: Article

References (47)

1. UNAIDS Joint United Nations Program on HIV/AIDS. AIDS epidemic update: December. Geneva: World Health Organization, 1999.
2. HIV/AIDS surveillance report. Vol. 10. No. 2. Atlanta: Centers for Disease Control and Prevention, 1998.
3. Vittinghoff E, Douglas J, Judson F, McKirnan D, MacQueen K, Buchbinder SP. Per-contact risk of human immunodeficiency virus transmission between male sexual partners. Am J Epidemiol 1999;150:306-11.
4. Shiboski SC, Padian NS. Epidemiologic evidence for time variation in HIV infectivity. J Acquir Immune Defic Syndr Hum Retrovirol 1999;19: 527-35.
5. Downs AM, De Vincenzi I, European Study Group in Heterosexual Transmission of HIV. Probability of heterosexual transmission of HIV: relationship to the number of unprotected sexual contacts. J Acquir Immune Defic Syndr Hum Retrovirol 1996;11:388-95.
6. Royce RA, Seña A, Cates WJ Jr, Cohen MS. Sexual transmission of HIV. N Engl J Med 1997;336:1072-8. [Erratum, N Engl J Med 1997;337:799.]
7. de Vincenzi I. A longitudinal study of human immunodeficiency virus transmission by heterosexual partners. N Engl J Med 1994;331:341-6.
8. Nelson KE, Rungruengthanakit K, Margolick J, et al. High rates of transmission of subtype E human immunodeficiency virus type 1 among heterosexual couples in northern Thailand: role of sexually transmitted dis eases and immune compromise. J Infect Dis 1999;180:337-43 [Erratum, J Infect Dis 1999;180:1756.]
9. Moses S, Bailey RC, Ronald AR. Male circumcision: assessment of health benefits and risks. Sex Transm Infect 1998;74:368-73.
10. Halperin DT, Bailey RC. Male circumcision and HIV infection: 10 years and counting. Lancet 1999;354:1813-5.
11. Cameron DW, Simonsen JN, D'Costa LJ, et al. Female to male transmission of human immunodeficiency virus type 1: risk factors for serocon-version in men. Lancet 1989;2:403-7.
12. Fleming DT, Wasserheit JN. From epidemiological synergy to public health policy and practice: the contribution of other sexually transmitted diseases to sexual transmission of HPV infection. Sex Transm Infect 1999; 75:3-17.
13. Cohen MS. Sexually transmitted diseases enhance HIV transmission: no longer a hypothesis. Lancet 1998;351:Suppl III:sIII5-sIII7.
14. Lee TH, Sakahara N, Fiebig E, Busch MP, O'Brien TR, Herman SA. Correlation of HIV-1 RNA levels in plasma and heterosexual transmission of HIV-1 from infected transfusion recipients. J Acquir Immune Defic Syndr Hum Retrovirol 1996;12:427-8.
15. Ragni MV, Faruki H, Kingsley LA. Heterosexual HIV-1 transmission and viral load in hemophilic patients. J Acquir Immune Defic Syndr Hum Retrovirol 1998;17:42-5.
16. Operskalski EA, Stram DO, Busch MP, et al. Role of viral load in heterosexual transmission of human immunodeficiency virus type 1 by blood transfusion recipients. Am J Epidemiol 1997;146:655-61.
17. Pedraza MA, del Romero J, Roldan F, et al. Heterosexual transmission of HFV-1 is associated with high plasma viral load levels and a positive viral isolation in the infected partner. J Acquir Immune Defic Syndr Hum Retrovirol 1999;21:120-5.
18. Moore JP. Coreceptors: implications for HIV pathogenesis and therapy. Science 1997;276:51-2.
19. Hoffman TL, MacGregor RR, Burger H, Mick R, Doms RW, Collman RG. CCR5 genotypes in sexually active couples discordant for human immunodeficiency virus type 1 infection status. J Infect Dis 1997;176: 1093-6.
20. Musicco M, Lazzarin A, Nicolosi A, et al. Antiretroviral treatment of men infected with human immunodeficiency virus type 1 reduces the incidence of heterosexual transmission. Arch Intern Med 1994;154:1971-6.
21. Wawer MJ, Sewankambo NK, Serwadda D, et al. Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Lancet 1999;353:525-35.
22. AIDS Control Programme. HIV testing policy. Entebbe, Uganda: Ministry of Health, Health Education Printing Press, October 1992:1-8.
23. Acquired immune deficiency syndrome (AIDS): workshop on AIDS in central Africa, Bangui, 22-25 October 1985. In: Weekly epidemiological record. Vol. 60. No. 44. Geneva: World Health Organization, 1985:342.
24. Garcia PM, Kalish LA, Pitt J, et al. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. N Engl J Med 1999;341:394-402.
25. Michael NL, Herman SA, Kwok S, et al. Development of calibrated viral load standards for group M subtypes of human immunodeficiency virus type 1 and performance of an improved AMPLICOR HIV-1 MONITOR test with isolates of diverse subtypes. J Clin Microbiol 1999;37:2557-63.
26. Armitage P. Statistical methods in medical research. Oxford, England: Oxford University Press, 1977.
27. Breslow NE, Day NE. Statistical methods in cancer research. Vol. 2. The design and analysis of cohort studies. Lyon, France: International Agency for Research on Cancer, 1987. (IARC scientific publications no. 82.)
28. Statistics Department, Ministry of Finance and Economic Planning and Demographic Health Surveys. Uganda demographic and health survey 1995. Calverton, Md.: Macro International, 1996:48.
29. Mock PA, Shaffer N, Bhadrakom C, et al. Maternal viral load and timing of mother-to-child HIV transmission, Bangkok, Thailand. AIDS 1999; 13:407-14
30. Mofenson LM, Lambert JS, Stiehm ER, et al. Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. N Engl J Med 1999;341:385-93.
31. Mayaux MJ, Dussaix E, Isopet J, et al. Maternal virus load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohort studies. J Infect Dis 1997;175: 172-5.
32. Shaffer N, Chuachoowong R, Mock PA, et al. Short-course zidovudine for perinatal HFV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Lancet 1999;353:773-80.
33. Sperling RS, Shapiro DE, Coombs RW, et al. Maternal viral load, zidovudine treatment, and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. N Engl J Med 1996;335:1621-9.
34. Gupta P, Mellors J, Kingsley L, et al. High viral load in semen of human immunodeficiency virus type 1-infected men at all stages of disease and its reduction by therapy with protease and nonnucleoside reverse transcriptase inhibitors. J Virol 1997;71:6271-5.
35. Hart CE, Lennox JL, Pratt-Palmore M, et al. Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract. J Infect Dis 1999;17:871-82.
36. Iversen AK, Larsen AR, Jensen T, et al. Distinct determinants of human immunodeficiency virus type 1 RNA and DNA loads in vaginal and cervical secretions. J Infect Dis 1998;177:1214-20.
37. Vernazza PL, Gilliam BL, Dyer J, et al. Quantification of HIV in semen: correlation with antiviral treatment and immune status. AIDS 1997; 11:987-93.
38. Haase AT, Schacker TW. Potential for the transmission of HFV-1 despite highly active antirctroviral therapy. N Engl J Med 1998;339:1846-8.
39. Zhang H, Dornadula G, Beumont M, et al. Human immunodeficiency virus type 1 in the semen of men receiving highly active antiretroviral therapy. N Engl J Med 1998;339:1803-9.
40. Coombs RW, Speck CE, Hughes JP, et al. Association between culturable human immunodeficiency virus type 1 (HFV-I) in semen and HFV-I RNA levels in semen and blood: evidence for compartmentalization of HIV-1 between semen and blood. J Infect Dis 1998;177:320-30.
41. Fiscus SA, Vernazza PL, Gilliam B, Dyer J, Eron JJ, Cohen MS. Factors associated with changes in HFV shedding in semen. AIDS Res Hum Retroviruscs 1998;14:Suppl 1:S27-S31.
42. Cohen MS, Hoffman IF, Royce RA, et al. Reduction of concentration of HIV-1 in semen after treatment of urethritis: implications for prevention of sexual transmission of HFV-I. Lancet 1997;349:1868-73.
43. Quinn TC. Global burden of the HFV pandemic. Lancet 1996;348: 99-106. [Erratum, Lancet 1996;348:276.]
44. Farzadegan H, Hoover DR, Astemborski J, et al. Sex differences in HFV-1 viral load and progression to AIDS. Lancet 1998;352:1510-4.
45. Sterling TR, Lyles CM, Vlahov D, Astemborski J, Margolick JB, Quinn TC. Sex differences in longitudinal human immunodeficiency virus type 1 RNA levels among scroconverters. J Infect Dis 1999;180:666-72.
46. Lavreys I, Rakwar JP, Thompson ML, et al. Effect of circumcision on incidence of human immunodeficiency virus type 1 and other sexually transmitted diseases: a prospective cohort study of trucking company employees in Kenya. J Infect Dis 1999;180:330-6.
47. Padian NS, Shiboski SC, Glass SO, Vittinghoff E. Heterosexual transmission of human immunodeficiency virus (HIV) in northern California: results from a ten-year study. Am J Epidemiol 1997;146:350-7.